• 18FFDG-based radiomics and machine learning: a useful help for aortic prosthetic valve infective endocarditis diagnosis?, Thomas Godefroy, Gauthier Frécon, Antoine Asquier-Khati, Diana Mateus, Raphael Lecomte, Mira Rizkallah, Nicolas Piriou, Thomas Le Tourneau, David Boutoille, Thomas Eugene et Thomas Carlier, European Heart Journal, 43(Supplement 2):ehac544–318, 2022. http://dx.doi.org/10.1093/eurheartj/ehac544.318

  • Immuno-PET: Design options and clinical proof-of-concept, Lugat, A ; Bailly, C ; Chérel, M ; Rousseau, C ; Kraeber-Bodéré, F ; Bodet-Milin, C & al, Front Med (Lausanne), 2022, 9, 1026083
    https://doi.org/10.3389/fmed.2022.1026083

  • Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma, Bailly, C ; Carlier, T ; Tessoulin, B ; Gastinne, T ; Kraeber-Bodere, F ; Le Gouill, S & al , Hematol Oncol, 2022, 40, 796-800
    https://doi.org/10.1002/hon.2965

  • Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study, Alberge JB, Kraeber-Bodéré F, Jamet B, Touzeau C, Caillon H, Wuilleme S, Béné MC, Kampfenkel T, Sonneveld P, van Duin M, Avet-Loiseau H, Corre J, Magrangeas F, Carlier T, Bodet-Milin C, Chérel M, Moreau P, Minvielle S, Bailly C. (DA), J Nucl Med, 2022, 63, 1008-1013
    https://doi.org/10.2967/jnumed.121.262884

  • Prognostic value of positron emission tomography/computed tomography in transplanteligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study, Kraeber-Bodéré, F ; Zweegman, S ; Perrot, A ; Hulin, C ; Caillot, D ; Facon, T & al , Haematologica, 2022
    https://doi.org/10.3324/haematol.2021.280051